Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
EndocrinologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Diabetes, obesity & metabolism
- Publicado em
- 6 jul 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
Jinhua Yan, Qiongyan Lin, Yongwen Zhou, Ying Ni, Ziqing Lin, Ping Ling, Zhe Dai, Jun Tang, Jinhua Yan
Descritores MeSH
- Insulin Infusion Systems
- Diabetes Mellitus, Type 1
- Hypoglycemic Agents
- Insulin
- Glycated Hemoglobin
- Humans
- Hypoglycemia
- Randomized Controlled Trials as Topic
- Diabetic Ketoacidosis
- Glycemic Control
Veja também
Estudos relacionados
- Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial
- Automated Insulin Delivery in Adults With Type 1 Diabetes and Suboptimal HbA1c During Prior Use of Insulin Pump and Continuous Glucose Monitoring: A Randomized Controlled Trial
- The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial
- Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials